Table VI.

Uni- and multivariate analyses of clinicopathological variables and the expression of CXCR1/2 with regard to T stage.

	Univariate analysis			Multivariate analysis
Variables	OR	95% CI	P-value	OR	95% CI	P-value
Differentiation (poor vs. moderate, good)	0.283	0.108–0.745	0.011	0.268	0.072–0.997	0.049
CXCR1/2 (negative, weak vs. strong)	4.039	1.448–11.257	0.008	8.101	1.861–35.269	0.005
pAKT (negative, weak vs. strong)	1.579	0.614–4.063	0.343	5.382	1.203–24.095	0.028
Ki-67 (negative, weak vs. strong)	0.396	0.140–1.123	0.081	0.149	0.026–0.843	0.031
EGFR (negative, weak vs. strong)	0.451	0.146–1.387	0.165	0.126	0.020–0.787	0.027
MVD (<20 vs. ≥20)	3.855	1.448–10.433	0.007	3.040	0.904–10.237	0.072

CXCR1/2, C-X-C chemokine receptor types 1/2; OR, odds ratio; 95% CI, 95% confidence interval; MVD, microvessel density.